Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.
| Image |  |
|---|---|
| Description | scientific article published on 09 April 2014 |
| Author/s |
author: Ruth Escalona Erik W. Thompson Michael A. Quinn Rodney B Luwor |
| Publication date | April 9, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |